Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Veracyte Inc - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
VCYT
Nasdaq
8071
https://www.veracyte.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Veracyte Inc
Estimating The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)
- Mar 23rd, 2023 10:54 am
Veracyte Announces Three Abstracts to Be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Multi-Omics Capabilities and Tools for Biopharma Partners
- Mar 15th, 2023 8:15 pm
7 Biotech Stocks That Could Be the Next Big Thing
- Mar 15th, 2023 3:44 pm
Veracyte Provides Statement on Impact of Events Surrounding Silicon Valley Bank
- Mar 11th, 2023 5:11 pm
Double-Digit Sales Growth: Is This Stock a Convincing Buy for Growth Investors?
- Mar 10th, 2023 2:30 pm
Veracyte to Participate in Upcoming Investor Conferences
- Feb 27th, 2023 10:00 pm
We're Interested To See How Veracyte (NASDAQ:VCYT) Uses Its Cash Hoard To Grow
- Feb 24th, 2023 10:42 am
Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates
- Feb 22nd, 2023 11:15 pm
Veracyte Announces Fourth Quarter and Full-Year 2022 Financial Results
- Feb 22nd, 2023 9:05 pm
Data Published in "The Red Journal" Validate Prognostic Value of Veracyte’s Decipher Prostate Genomic Classifier for Men with High-Risk Prostate Cancer
- Feb 15th, 2023 1:36 pm
New Data To Be Presented at 2023 ASCO GU Suggest Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment
- Feb 13th, 2023 10:23 pm
‘Stay Long and Strong’: Billionaire Ken Fisher Snaps Up These 2 ‘Strong Buy’ Stocks
- Feb 13th, 2023 3:14 pm
Veracyte to Release Fourth Quarter and Full-Year 2022 Financial Results on February 22, 2023
- Feb 6th, 2023 10:00 pm
Veracyte Announces Multiple Decipher Urologic Testing Abstracts to be Presented at the 2023 ASCO Genitourinary (GU) Cancers Symposium
- Feb 1st, 2023 9:05 pm
Veracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid Nodules
- Feb 1st, 2023 1:32 pm
Better Long-Term Buy in 2023: Exact Sciences or Veracyte?
- Jan 24th, 2023 3:23 pm
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
- Jan 23rd, 2023 2:00 pm
This Small-Cap Stock Is a No-Brainer Buy
- Jan 18th, 2023 11:10 am
Terex and Armstrong World Industries have been highlighted as Zacks Bull and Bear of the Day
- Dec 22nd, 2022 1:54 pm
3 Medical Instruments Stocks on Recovery Path After Dismal 2022
- Dec 21st, 2022 2:08 pm
Scroll